Jul 21 |
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
|
Jul 9 |
AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know
|
Jun 25 |
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
|
Jun 6 |
We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate
|
May 28 |
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
|
May 16 |
AbCellera: If You Build It, Will They Come? Fresh Impetus Required
|
May 16 |
AbCellera: Cash Providing Shelter From Market Weakness
|
May 10 |
Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71
|
May 8 |
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript
|
May 8 |
Q1 2024 Abcellera Biologics Inc Earnings Call
|